| 1 | Business Review | Matthew McKENZIE-SMITH | 108 |
|
| 2 | Fortune 500 | Matthew McKENZIE-SMITH | 120 |
|
| 3 | Active Molecules | Matthew McKENZIE-SMITH | 112 |
|
| 4 | Emerging Market | Matthew McKENZIE-SMITH | 120 |
|
| 5 | Electrode | Matthew McKENZIE-SMITH | 117 |
|
| 6 | Money Minute | Matthew McKENZIE-SMITH | 118 |
|
| 7 | Biomedics | Matthew McKENZIE-SMITH | 102 |
|
| 8 | Growth & Development | Matthew McKENZIE-SMITH | 120 |
|
| 9 | Brain Patterns | Matthew McKENZIE-SMITH | 95 |
|
| 10 | Brain Patterns | Matthew McKENZIE-SMITH | 95 |
|
| 11 | Delicate Procedure | Matthew McKENZIE-SMITH | 120 |
|
| 12 | After Care | Matthew McKENZIE-SMITH | 85 |
|
| 13 | Financial News | Matthew McKENZIE-SMITH | 152 |
|
| 14 | Financial News | Matthew McKENZIE-SMITH | 152 |
|
| 15 | Business Review | Matthew McKENZIE-SMITH | 108 |
|
| 16 | Fortune 500 | Matthew McKENZIE-SMITH | 120 |
|
| 17 | Active Molecules | Matthew McKENZIE-SMITH | 112 |
|
| 18 | Emerging Market | Matthew McKENZIE-SMITH | 120 |
|
| 19 | Electrode | Matthew McKENZIE-SMITH | 117 |
|
| 20 | Money Minute | Matthew McKENZIE-SMITH | 118 |
|
| 21 | Biomedics | Matthew McKENZIE-SMITH | 102 |
|
| 22 | Growth & Development | Matthew McKENZIE-SMITH | 120 |
|
| 23 | Brain Patterns | Matthew McKENZIE-SMITH | 95 |
|
| 24 | Delicate Procedure | Matthew McKENZIE-SMITH | 120 |
|
| 25 | After Care | Matthew McKENZIE-SMITH | 85 |
|
| 26 | Financial News | Matthew McKENZIE-SMITH | 152 |
|
